 Ifosfamide continuous infusion mesna phase trial cycle patients courses ifosfamide continuous infusion days Mesna goal study dose rate total cumulative dose ifosfamide comparable bolus short-term infusions Mesna Dose escalations patients transient microscopic hematuria instances macroscopic hematuria patients nonurologic toxicity confusion nausea Grade leukopenia recommended dose delivers total dose cycle comparable clinical practice bolus short-term infusion patients multiple courses time cumulative effects indeterminate present trial frequency predictability hematuria precise daily monitoring urine Hematest essential Mesna infusate patients persistent hematuria protracted infusion schedule ifosfamide permits convenient outpatient administration Mesna drug cost clinical usage agent cycle Clinical activity single patient comparative trial standard bolus schedules protracted infusion schedule necessary clinical effectiveness drug